LYV:NYSELive Nation Entertainment, Inc. Analysis
Data as of 2026-05-22 - not real-time
$165.86
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Live Nation (LYV) is trading at $165.86, comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating a short‑term bullish bias despite a bearish MACD histogram and decreasing volume. Revenue growth of 12.2% year‑over‑year and a 30‑day volatility of over 36% reflect a dynamic market environment, while the company posted a GAAP loss of $1.85 per share in Q1 2026, missing earnings expectations but beating consensus on the loss magnitude. The forward P/E of 77x dwarfs the industry average of 17x, suggesting the stock appears overvalued on a pure earnings multiple, yet the discounted cash flow model estimates a fair value of $191.20, implying roughly an 11% upside from current levels. Balance sheet pressure is evident with $10.6 B of debt against $9.1 B of cash and a debt‑to‑equity ratio exceeding 700, while book value per share is negative, eliminating any dividend sustainability. Analyst consensus remains a “Buy” with median price targets near $190, driven by expectations that a larger share of concert growth will materialize in Q3 and beyond.
The stock’s beta of ~0.8 points to lower systematic risk than the market, but high historical drawdowns of nearly 28% and a sharp drop in trading volume raise liquidity concerns. Regulatory scrutiny of ticketing platforms and antitrust exposure add a medium regulatory risk, while global operations introduce moderate geographic risk but limited currency risk as most revenue is USD‑denominated. Given the mixed technical signals, strong top‑line growth, and a DCF‑derived upside, the recommendation leans toward a cautious buy stance across horizons, with heightened attention to debt servicing and quarterly earnings trends.
The stock’s beta of ~0.8 points to lower systematic risk than the market, but high historical drawdowns of nearly 28% and a sharp drop in trading volume raise liquidity concerns. Regulatory scrutiny of ticketing platforms and antitrust exposure add a medium regulatory risk, while global operations introduce moderate geographic risk but limited currency risk as most revenue is USD‑denominated. Given the mixed technical signals, strong top‑line growth, and a DCF‑derived upside, the recommendation leans toward a cautious buy stance across horizons, with heightened attention to debt servicing and quarterly earnings trends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings miss and decreasing volume
- Bearish MACD histogram despite price above SMAs
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 12% revenue growth and expected Q3 concert surge
- DCF fair‑value upside of ~11%
- Analyst consensus and price‑target support
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Structural shift toward live entertainment experiences
- Strong ticketing platform and sponsorship ecosystem
- Potential to improve profitability as debt is managed
Key Metrics & Analysis
Financial Health
Revenue Growth12.20%
Profit Margin0.33%
P/E Ratio77.2
ROE14.93%
ROA2.18%
Debt/Equity738.27
P/B Ratio-274.6
Op. Cash Flow$2.4B
Free Cash Flow$2.1B
Industry P/E17.0
Technical Analysis
TrendBullish
RSI55.8
Support$151.44
Resistance$173.12
MA 20$162.75
MA 50$158.63
MA 200$153.11
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8
Valuation
Fair Value$191.20
Target Price$184.78
Upside/Downside11.41%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.80
Volatility36.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.